Janus Henderson Investors US’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Janus Henderson Investors US’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$67.2M	Sell	562,374 -22,529	-4%	-$2.36M	0.06%	370
2016 Q4	$58.1M	Buy	584,903 +32,637	+6%	+$3.44M	0.05%	408
2016 Q3	$61.9M	Sell	552,266 -28,878	-5%	-$3.47M	0.05%	390
2016 Q2	$59.7M	Buy	581,144 +3,564	+0.6%	+$356K	0.05%	390
2016 Q1	$53M	Buy	577,580 +156,261	+37%	+$16.7M	0.05%	414
2015 Q4	$60.8M	Buy	421,319 +104,708	+33%	+$13.6M	0.05%	373
2015 Q3	$32.7M	Buy	316,611 +142,182	+82%	+$16.7M	0.03%	502
2015 Q2	$28.4M	Buy	+174,429	New	+$29.6M	0.02%	547

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Janus Henderson Investors US's SIOX Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Sio Gene Therapies Inc. Common Stock (SIOX) stake by 3.9% in Q1 2017, selling an estimated $2.36M and leaving 562,374 shares worth $67.2M. The position accounts for 0.06% of the portfolio, ranked #370.

Janus Henderson Investors US first reported a position in SIOX in Q2 2015 and has held it in 8 quarters since. 97 funds tracked by Wall St. Rank hold SIOX as of Q1 2017.

Janus Henderson Investors US held 562,374 shares of Sio Gene Therapies Inc. Common Stock worth $67.2M as of Q1 2017.
Janus Henderson Investors US sold 22,529 Sio Gene Therapies Inc. Common Stock shares in Q1 2017, an estimated $2.36M.
Sio Gene Therapies Inc. Common Stock made up 0.06% of Janus Henderson Investors US's portfolio in Q1 2017, its #370 holding.
Janus Henderson Investors US first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and has held it in 8 quarters since.
97 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.